MENU
AFMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Affimed (AFMD) Earnings Date & Reports

Affimed NV is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AFMD is expected to report earnings to fall 6.27% to -56 cents per share on May 21

Affimed AFMD Stock Earnings Reports
Q1'25
Est.
$-0.57
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.28
The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -71 cents. With 100.05K shares outstanding, the current market capitalization sits at 11.67M.
View a ticker or compare two or three
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of antibody-based therapeutic drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Gottlieb-Daimler-Strabe 2
Phone
+49 621560030
Employees
78
Web
https://www.affimed.com